Dihexa
Dihexa, also known as PNB-0408 and chemically identified as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, is a synthetic Ang IV-derived peptidomimetic related to the renin–angiotensin research pathway. It has attracted interest in neuroscience research due to its reported effects on synaptogenesis and its potential relevance to cognitive function and neurodegenerative disease models. As a small synthetic peptide-like molecule, Dihexa has been reported in experimental studies to show oral activity and blood–brain barrier permeability.
Dihexa
Sale!
Dihexa, also known as PNB-0408 and chemically identified as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, is a synthetic Ang IV-derived peptidomimetic related to the renin–angiotensin research pathway. It has attracted interest in neuroscience research due to its reported effects on synaptogenesis and its potential relevance to cognitive function and neurodegenerative disease models. As a small synthetic peptide-like molecule, Dihexa has been reported in experimental studies to show oral activity and blood–brain barrier permeability.
$112.00
Buy more, save more!
-
Save 2%
Buy 3, get $2.50 off each
$112.00Per item: $109.50Total price: $328.50 -
Save 3%
Buy 5, get $3.75 off each
$112.00Per item: $108.25Total price: $541.25 -
Save 7%
Buy 10, get $7.50 off each
$112.00Per item: $104.50Total price: $1,045.00
$120.00$112.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
Dihexa has been investigated for its interaction with hepatocyte growth factor (HGF)-related pathways. The compound is primarily studied for its ability to bind HGF and potentiate HGF-dependent c-Met receptor signalling, pathways involved in cellular communication, synaptic plasticity, and neurotrophic processes in experimental models.
Dihexa has been associated with mechanisms linked to neuronal connectivity, spinogenesis, and synaptogenesis. However, its evidence base remains primarily preclinical.
There are no reviews yet.